Post by alexricharlison717 on Jan 9, 2024 2:28:06 GMT -5
Multiplex testing kits for use with the binx io(R) platform will reduce wait times for test results and improve patient access to treatment. binx health(TM), a company pioneering treatment everywhere ( anywhere care) announced that the company's gonorrhea and chlamydia testing kit (CT/NG) has received the European Union's CE Mark certification. This multiplex test kit works with the binx io platform and can produce laboratory-quality results in just 30 minutes, setting a new standard for "Testing and treating" the most common sexually transmitted infections worldwide. Each day there are more than one million sexually transmitted infections worldwide.
Gonorrhea and chlamydia are the two most common diseases [1]. Latest data from the European Center for Disease Control and Prevention (ECDC) indicates that in EU member states and the European Economic Area, People infected with gonorrhea increased 17% from 2016 to 2017, with Phone Number Data some countries experiencing an increase of more than 40% year-on-year. [2] In the United States, Infection rates have also jumped 67% since 2013, with the highest number of cases being those aged 20-24 [3]. Currently, most gonorrhea and chlamydia testing is sent to central laboratory Therefore, you may have to wait for results for up to 7 days. Patients may infect others during that time, and 40% of infected patients do not return for treatment[4]. binx health wants to change that situation.
By helping patients and consumers leave the pharmacy Primary health care units, clinics, urgent care centers and other forms of medical facilities which received treatment from the first visit (binx io platform is not yet available in the United States But the company has just completed clinical trials. to submit information to the Food and Drug Administration for 510(k) license). The binx io platform is designed to be easy to use. It can be used by people who do not have laboratory level training and can use it with the same level of accuracy as testing in a central laboratory. Therefore suitable for use by general consumers or medical use.
Gonorrhea and chlamydia are the two most common diseases [1]. Latest data from the European Center for Disease Control and Prevention (ECDC) indicates that in EU member states and the European Economic Area, People infected with gonorrhea increased 17% from 2016 to 2017, with Phone Number Data some countries experiencing an increase of more than 40% year-on-year. [2] In the United States, Infection rates have also jumped 67% since 2013, with the highest number of cases being those aged 20-24 [3]. Currently, most gonorrhea and chlamydia testing is sent to central laboratory Therefore, you may have to wait for results for up to 7 days. Patients may infect others during that time, and 40% of infected patients do not return for treatment[4]. binx health wants to change that situation.
By helping patients and consumers leave the pharmacy Primary health care units, clinics, urgent care centers and other forms of medical facilities which received treatment from the first visit (binx io platform is not yet available in the United States But the company has just completed clinical trials. to submit information to the Food and Drug Administration for 510(k) license). The binx io platform is designed to be easy to use. It can be used by people who do not have laboratory level training and can use it with the same level of accuracy as testing in a central laboratory. Therefore suitable for use by general consumers or medical use.